← FDA Drug Approvals (Drugs@FDA)

TAVABOROLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS LIFESCIENCES · Approved 2023-04-10

Drug application

FDA Application #

ANDA212294

Application type

Abbreviated New Drug Application (Generic)

Brand name

TAVABOROLE

Generic name

TAVABOROLE

Active ingredients

TAVABOROLE

Dosage form

SOLUTION

Route

TOPICAL

Marketing status

Prescription

Sponsor

ZYDUS LIFESCIENCES

Manufacturer

Zydus Lifesciences Limited

First approval

2023-04-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown